Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-13
2007-11-13
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S202000, C548S203000, C548S204000, C548S205000
Reexamination Certificate
active
11040522
ABSTRACT:
The present invention relates to substituted thiazole derivatives that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin and MCAK activity, and for inhibiting KSP kinesin and MCAK. The invention also relates to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
REFERENCES:
patent: 0169502 (1990-10-01), None
patent: 94/08982 (1994-04-01), None
patent: WO 01/17995 (2001-03-01), None
patent: WO 02/45652 (2002-06-01), None
patent: 03/006437 (2003-01-01), None
patent: WO 03/006015 (2003-01-01), None
Kumita et al. I, “Synthesis of”, CA 135:89707, 2001.
Pons et al., “Thiazole formation, etc.,” Tetrahedron Letters 41 (2000) 4965-4968.
Sanchez-Viesca et al., “Synthesis and, etc.,” CA 124:86858, 1995.
Katrizky et al., “1-(Cyanomethyl)benzotriazole, etc.,” J. Org. Chem. 1995, 60, 5638-5642.
Arulmoli et al., “Synthesis and, etc.,” CA 123:111915, 1995.
Manian et al., “Synthesis of, etc.,” CA 122: 133044, 1995.
Sugiyama et al., “Preparation of salicylic, etc.,” CA 117: 212486, 1992.
Al-Azawe et al., “Synthesis and bromination, etc.,” CA 114: 81673, 1991.
Noda et al., “Phenylacetic acid, etc.,” CA 92: 58760, 1980.
Patil et al. I, “Synthesis and, etc.,” CA 90: 103886, 1979.
Patil et al., II, “Synthesis and, etc.,” CA 89: 146824, 1978.
Patil et al., III, “Synthesis and, etc.,” CA 85: 192613, 1976.
Colah et al., “Antiinflammatory agents, etc.,” CA 87: 68218, 1977.
Chaudhari et al., I, “Potential anticancer, etc.,” CA 86: 171308, 1977.
Chaudhari et al., II, “Synthesis and, etc.,” CA 85: 159962, 1976.
Chaudhari et al., III, “Potential anticancer, etc.,” CA 84: 90050, 1976.
Kulkami et al., “Chemortherapy of, etc.,” CA 71:79422, 1969.
Sabnis, “Synthesis of potential, etc.,” CA 69:43837, 1968.
Kenner, GW., et al., Tetrahedron Letters, p. 23-26 (1960).
Cross, DFW., et al., J. Chem. Soc., p. 2143-2150 (1963).
Coleman Paul J.
Garbaccio Robert M.
Neilson Lou Anne
Beeler Nicole M.
Merck & Co. , Inc.
Morris Patricia L.
Muthard David A.
LandOfFree
Mitotic kinesin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mitotic kinesin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitotic kinesin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822184